Connection
Nichole Carlson to Parkinson Disease
This is a "connection" page, showing publications Nichole Carlson has written about Parkinson Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.888 |
|
|
|
-
Carlisle TC, Gunn-Sandell LB, Lippitt WL, Zhu S, Medina LD, Holden SK, Amara AW, Bettcher BM, Carlson NE. Refining the Parkinson's Disease Risk Estimator for Decline In Cognition Tool (PREDICT). Cogn Behav Neurol. 2026 06 01; 39(2):64-73.
Score: 0.605
-
Nutt JG, Carter JH, Carlson NE. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial. Arch Neurol. 2007 Mar; 64(3):319-23.
Score: 0.159
-
Gunzler SA, Pavel M, Koudelka C, Carlson NE, Nutt JG. Foot-tapping rate as an objective outcome measure for Parkinson disease clinical trials. Clin Neuropharmacol. 2009 Mar-Apr; 32(2):97-102.
Score: 0.046
-
Gunzler SA, Koudelka C, Carlson NE, Pavel M, Nutt JG. Effect of low concentrations of apomorphine on parkinsonism in a randomized, placebo-controlled, crossover study. Arch Neurol. 2008 Feb; 65(2):193-8.
Score: 0.042
-
Chung KA, Carlson NE, Nutt JG. Short-term paroxetine treatment does not alter the motor response to levodopa in PD. Neurology. 2005 May 24; 64(10):1797-8.
Score: 0.035